Successful treatment with omalizumab of a child affected by systemic mastocytosis: clinical and biological implications

HIGHLIGHTS

• who: Grazia Bossi from the Department of Pediatrics, Fondazione , Pavia, Italy Pediatric School of Specialization, University of Pavia, Pavia, Italy have published the research work: Successful treatment with Omalizumab of a child affected by Systemic Mastocytosis: clinical and biological implications, in the Journal: (JOURNAL)
• what: Hereby the authors report the case of a patient affected by SM, refractory to traditional medications, treated with Omalizumab, who obtained complete symptoms remission and a significant improvement in quality of life.
• future: More extensive and controlled studies in pediatric patients affected by Systemic Mastocytosis are needed to . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.